These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1694921)

  • 21. Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action.
    Sanguinetti MC; Jurkiewicz NK; Scott A; Siegl PK
    Circ Res; 1991 Jan; 68(1):77-84. PubMed ID: 1984874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological and inotropic characterization of a novel class III antiarrhythmic agent, GLG-V-13, in the mammalian heart.
    Fazekas T; Carlsson L; Scherlag BJ; Mabo P; Poty H; Palmer M; Patterson E; Berlin KD; Garrison GL; Lazzara R
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):182-91. PubMed ID: 8856472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms underlying the reentrant circuit of atrioventricular nodal reentrant tachycardia in isolated canine atrioventricular nodal preparation using optical mapping.
    Wu J; Wu J; Olgin J; Miller JM; Zipes DP
    Circ Res; 2001 Jun; 88(11):1189-95. PubMed ID: 11397786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of atrioventricular nodal "slow pathway" for simultaneous treatment of coexisting atrioventricular and nodal reciprocating tachycardias.
    Di Biase L; Bai R; Tritto M; Grimaldi M; Biasco MG
    J Interv Card Electrophysiol; 2007 Aug; 19(2):143-7. PubMed ID: 17668304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiarrhythmic actions of diltiazem during experimental atrioventricular reentrant tachycardias. Importance of use-dependent calcium channel-blocking properties.
    Talajic M; Papadatos D; Villemaire C; Nayebpour M; Nattel S
    Circulation; 1990 Jan; 81(1):334-42. PubMed ID: 2297837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Catheter ablation in supraventricular tachycardia].
    Pitschner HF; Neuzner J
    Z Kardiol; 1996; 85 Suppl 6():45-60. PubMed ID: 9064982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiarrhythmic treatment of atrioventricular tachycardias.
    Goy JJ; Fromer M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S36-40. PubMed ID: 1723116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters.
    Wettwer E; Scholtysik G; Schaad A; Himmel H; Ravens U
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):480-7. PubMed ID: 1711611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slow abnormal conduction in the low right atrium: its anatomic basis and relevance to atrial reentry.
    Yamashita T; Oikawa N; Inoue H; Murakawa Y; Nakajima T; Usui M; Ajiki K; Ohkawa S; Sugimoto T
    Am Heart J; 1994 Feb; 127(2):353-9. PubMed ID: 8296703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
    Ogawa S; Mitamura H; Katoh H
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective Ik blocker almokalant exhibits class III--specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings.
    Darpö B; Vallin H; Almgren O; Bergstrand R; Insulander P; Edvardsson N
    J Cardiovasc Pharmacol; 1995 Oct; 26(4):530-40. PubMed ID: 8569212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained intraatrial reentrant tachycardia: clinical, electrocardiographic and electrophysiologic characteristics and long-term follow-up.
    Haines DE; DiMarco JP
    J Am Coll Cardiol; 1990 May; 15(6):1345-54. PubMed ID: 2329238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ; Nathan AW; Bexton RS; Spurrell RA; Camm AJ
    Am J Cardiol; 1983 Mar; 51(5):770-6. PubMed ID: 6829436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiologic effects and efficacy of cibenzoline in patients with supraventricular tachycardia.
    Fujiki A; Mizumaki K; Tani M; Yoshida S; Sasayama S
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):375-9. PubMed ID: 1279281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Electrophysiological effects of antiarrhythmic drug UK-68798 on different AV nodal cells in rabbit heart].
    Gao TL; Beyer T; Brachmann J
    Sheng Li Xue Bao; 1994 Jun; 46(3):258-66. PubMed ID: 7973813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular electrophysiological effects of the class III antiarrhythmic agents sematilide and clofilium on rabbit atrial tissues.
    Argentieri TM; Carroll MS; Sullivan ME
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):167-74. PubMed ID: 1719286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of E4031 and quinidine on atrial and ventricular refractoriness in rabbits in vivo.
    Chan AP; Leung MW; So PP; Guppy LJ; Walker MJ
    Proc West Pharmacol Soc; 2004; 47():39-41. PubMed ID: 15633608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of AHR-12234 on cardiac transmembrane action potentials, in situ cardiac electrophysiology and experimental models for arrhythmias.
    Wu KM; Proakis AG; Hunter TL; Shanklin JR
    Arch Int Pharmacodyn Ther; 1989; 301():131-50. PubMed ID: 2624512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mechanisms of spontaneous termination of reentrant supraventricular tachycardias.
    Chiale PA; Baranchuk A; González MD; Sánchez RA; Garro HA; Fernández PA; Avalos CQ; Enriquez A; Elizari MV
    Int J Cardiol; 2015 Jul; 191():151-8. PubMed ID: 25965623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.